Skip to content

Homoeopathic management in cases of sciatica along with Physiotherapy

A Comparative prospective study to ascertain the role of Gnaphalium Polycephalum alongwith Physiotherapy in management of Sciatica - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066767
Enrollment
84
Registered
2024-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G570- Lesion of sciatic nerve

Interventions

Intervention1: HOMOEOPATHIC MEDICINE -GNAPHALIUM POLYCEPHALUM: ACCORDING TO SUCEPTIBILITY OF PATIENT FOR EXAMPLE 30, 200,1M ROUTE OF ADMINISTRATION: ORAL DURATION OF TRIAL - 12 MONTHS Control Interven

Sponsors

AHMEDABAD HOMOEOPATHIC MEDICAL COLLAGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients presenting with clinical features of sciatica or pre-diagnosed cases of sciatica -Patients suffering from sciatica, willing to participate and taking treatment regularly and co-operating for regular follow-up and giving consent for the study will be included. -Patients presenting with totality of Gnaphalium

Exclusion criteria

Exclusion criteria: -Patients reporting with neurological or surgical complications. -Patients not coming for consecutive 3 follow-ups

Design outcomes

Primary

MeasureTime frame
To establish scope of homoeopathic medicine Gnaphalium Polycephalum in management of sciatica 2. Homoeopathic management along physiotherapy beneficial for sciatica patientTimepoint: 8 WEEKS

Secondary

MeasureTime frame
Homoeopathic management along physiotherapy beneficial for sciatica patientTimepoint: 8 WEEKS

Countries

India

Contacts

Public ContactDr. Gaurav Bhatt

Jawaharla Nehru Homoeopathic Medical, Parul university

kirtida.desai@paruluniversity.ac.in9898299611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026